Genmab — November 2018
-
Interessant teori, hvis JnJ vil give rabatter mhp Genmab ikke når i mål med guidance, hvilket vil blive straffet kursmæssigt og herefter blive et billigere opkøbsmål i 2019, hvor de ikke kan undgå de højere royalties. Enkelt men rationel købmandsskab.
-
JnJ deltog i Credit Suisse Healthcare Conference i går med knap en halv times Q&A. Efter ca. 15:14 tales der om DARA. Her bekræfter JnJ at "DARA og CAR-T in future will be working in a complementary way…". https://event.webcasts.com/viewer/event.jsp?ei=1217703&tp_key=75e5346a92
-
Genmab 6 min. inde i udsendelsen: https://www.radio24syv.dk/programmer/millionaerklubben/37397963/den-talmodige-investor
-
Very positive indeed.
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind